Navigation Links
Clinsys(R) TPS Teams Provide Comprehensive Clinical Development Plans
Date:4/9/2008

ent, and Chief Scientific Officer. With more than 25 years of Phase I-IV clinical trial experience and 10 years of pharmaceutical experience, she will select appropriate team members and provide strategic medical and scientific guidance throughout all phases of project/program planning and execution to ensure cohesive, consistent delivery of TPS services. Dr. Miller trained at Memorial Sloan-Kettering Cancer Center in the design and conduct of new agent trials.

The TPS teams are supported by Chris Gregory, PhD, Senior Director, Clinical Development, and Nermina Nakas, MD, MPH, Director, Clinical Development. Dr. Gregory brings more than 15 years of biotechnology/pharmaceutical and academic experience, with special attention to Alzheimer disease, Parkinson disease and multiple sclerosis. Dr. Nakas applies more than 22 years of clinical, academic and industry research experience in multiple therapeutic areas, with specific emphasis on respiratory disease, dermatology and pediatrics. Joining Drs. Gregory and Nakas in Clinical Development is Daniel Wood, PhD, Senior Clinical Research Scientist. Dr. Wood develops and prepares clinical trial synopses and protocols for designated therapeutic areas.

Recently, John Oh, MD, MBA, joined Clinsys as Director, Clinical Development. He will develop the TPS pain, stroke, traumatic brain injury and spinal cord injury programs, drawing on his experience directing programs in neurorehabilitative medicine and physical medicine and rehabilitation. Prior to joining Clinsys, Dr. Oh served as Director, Medical Affairs, for a global CRO. He also assisted with development of a commercialization plan for SBIR and NIH grants for a functional MRI analysis and data management system at several start-up companies. Dr. Oh, who received his MD from Temple University and his MBA from Duke University, served as the Residency Program Director and an investigator for clinical trials at the University of North Carolina School of Medicine.
'/>"/>

SOURCE Clinsys Clinical Research, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Pharmatech Teams up With Systems Medicine LLC and the Sarcoma Foundation of America for a Phase II Myxoid Liposarcoma Trial
2. Harris Corporation Teams with Cancer Treatment Services International to Advance Oncology Treatment
3. Michael J. Fox Foundation Awards Up to $3 Million to Industry Teams to Jumpstart Promising PD Drug Development
4. National Wrestling Coaches Association Teams Up With CSG/SportsCoatings(TM)
5. Three Dimensional Visualization of Right Ventricle Provides Important Information for Treatment of Patients with Tetralogy of Fallot, According to a Study in The American Journal of Cardiology
6. InterMune Provides Additional Information on ITMN-191 (R7227) MAD Study Results
7. InterMune Announces Top-Line Results of Phase 1b Trial of ITMN-191 (R7227) and Provides Program Update
8. Monogram Biosciences Provides Progenics Pharmaceuticals with HIV Assays for Use in Clinical Trials
9. Trubion Initiates Phase 1/2 Study of TRU-016 in CLL, Announces Next-Generation Product Candidate for RA and Provides Product Pipeline Update
10. Stem Cell Research Provides Medical Breakthrough to Repair Heart Cell Damage Created by a Heart Attack
11. Indevus Pharmaceuticals Provides Update on PRO 2000 Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2015)... 1, 2015 Ardelyx, Inc. (NASDAQ: ... gastrointestinal and cardio-renal diseases, today announced that Sanofi ... and license agreement for Ardelyx,s portfolio of NaP2b ... payment associated with termination and the return of ... Sanofi entered into an option and license agreement ...
(Date:9/1/2015)... 1, 2015 Emerus Holdings, a national ... inpatient and diagnostic care in partnership with leading ... definitive agreement to receive a strategic investment from ... leading health care investment firm. Emerus ... acute episodic and ambulatory clinical services to communities ...
(Date:9/1/2015)... --  Alpha Imaging LLC , a leading distributor of advanced medical ... that they have been awarded exclusive rights to represent the complete ... new territory supplements Alpha Imaging,s existing Shimadzu sales and service responsibilities ... , Indiana , Pennsylvania , ... West Virginia , Delaware and ...
Breaking Medicine Technology:Ardelyx Regains NaP2b Program from Sanofi 2Ardelyx Regains NaP2b Program from Sanofi 3Emerus Announces Significant Strategic Investment By Welsh, Carson, Anderson & Stowe 2Emerus Announces Significant Strategic Investment By Welsh, Carson, Anderson & Stowe 3Alpha Imaging Expands Shimadzu Territory 2
... at Brigham and Women,s,Hospital found that patients taking cannabinoid ... were unrelated to relief from their pain,symptoms. Results ... the addictive,potential of this class of pain medicine, were ... Annual Meeting. , In the ...
... The Netherlands, January 28 ,Amsterdam Molecular Therapeutics ... of,human gene therapy, announced today during the ... showing that one treatment of its lead ... and clinically important,lowering of the incidence of ...
Cached Medicine Technology:Study of Cannabinoid Medicine for Pain Found Patients Got 'High,' but Effects Not Related to Pain Relief 2AMT: Glybera(R) Lowers Pancreatitis Incidence Significantly 2AMT: Glybera(R) Lowers Pancreatitis Incidence Significantly 3
(Date:9/1/2015)... (PRWEB) , ... September 01, 2015 , ... ... by members of the American Society for Dermatologic Surgery, according to a new ... 2015 ASDS Consumer Survey on Cosmetic Dermatologic Procedures – which reflects views on ...
(Date:9/1/2015)... ... 01, 2015 , ... Negative pressure wound therapy (NPWT) entails ... remove exudates, fluid, and infectious materials to prepare the wound for healing and ... and canisters, etc.) is projected to expand continuously through 2021. , Rising patient ...
(Date:9/1/2015)... ... September 01, 2015 , ... OncLive® today ... U.S. News & World Report, to provide breaking news and information about the ... groups within OncLive, which provides oncologists resources and information?they need to deliver the ...
(Date:9/1/2015)... , ... September 01, 2015 , ... ... monitoring and analysis of pet vital signs and activity, today announced its integration ... of the most popular and widely-adopted veterinary hospital Practice Management Software packages in ...
(Date:9/1/2015)... ... September 01, 2015 , ... e-Spirit ... version 5.2 of the FirstSpirit Content Management System with new capabilities and enhancements ... version of FirstSpirit, companies will be well on their way to achieving digital ...
Breaking Medicine News(10 mins):Health News:Survey: Consumers Prefer ASDS Members 2Health News:Survey: Consumers Prefer ASDS Members 3Health News:World Negative Pressure Wound Therapy Market Assessed by GlobalData in In-demand Report Published at MarketPublishers.com 2Health News:World Negative Pressure Wound Therapy Market Assessed by GlobalData in In-demand Report Published at MarketPublishers.com 3Health News:OncLive® and Cleveland Clinic Team up to Provide News, Information About Cancer Research and Patient Care 2Health News:OncLive® and Cleveland Clinic Team up to Provide News, Information About Cancer Research and Patient Care 3Health News:Petpace-Cornerstone Integration Lowers Overhead, Raises Data Visibility for Veterinary Practices 2Health News:e-Spirit boosts Corporate Content Cloud initiative with release of FirstSpirit 5.2 2Health News:e-Spirit boosts Corporate Content Cloud initiative with release of FirstSpirit 5.2 3
... Days before national SEIU officials are expected to ... an off-duty police officer apparently hired as a private ... assaulted a UHW staff member."Before I even saw the ... said Andrea Carol, a UHW member and food service ...
... during breast-feeding, but resistant disease can develop in first ... -- The antiretroviral drug nevirapine may help prevent babies ... but it also greatly increases the odds of developing ... year of life, a new study finds. , Still, ...
... and change (improve) vision especially if you are named Barack Hussein ... ... honor of the Presidential Inauguration on Tuesday, January 20, Khanna ... any US citizen named "Barack Hussein Obama". "This is a historic ...
... School of Massage, taking the National Certification Examination for Therapeutic Massage ... points higher than the national average. , ... Atlanta, ... Massage (atlantaschoolofmassage.com), taking the National Certification Examination for Therapeutic Massage for ...
... Subsequent Offering Period NEW BRUNSWICK, N.J., Jan. 17 Johnson ... the initial tender offer, through its wholly owned subsidiary, Maple ... of Mentor Corporation (NYSE: MNT ) expired at ... not extended.The depositary for the tender offer has advised Johnson ...
... included Famous Amos and Keebler peanut butter cookies; FDA ... toll now stands at 452 sick in 43 states ... FRIDAY, Jan. 16 (HealthDay News) -- Cereal giant Kellogg ... U.S. health officials expanded their investigation into peanut products ...
Cached Medicine News:Health News:As SEIU Prepares Hostile Takeover of United Healthcare Workers, Surveillance of Local Union Office Ends in Assault by Off-Duty Police Officer 2Health News:As SEIU Prepares Hostile Takeover of United Healthcare Workers, Surveillance of Local Union Office Ends in Assault by Off-Duty Police Officer 3Health News:HIV Drug a Double-Edged Sword for Infants 2Health News:LASIK Surgery for "Barack Hussein Obama" 2Health News:Atlanta School of Massage Grads Beat National Test Scores By Wide Margin 2Health News:Johnson & Johnson Completes Initial Tender Offer for Mentor Corporation with 92.9% of Shares Tendered 2Health News:Johnson & Johnson Completes Initial Tender Offer for Mentor Corporation with 92.9% of Shares Tendered 3Health News:Kellogg Recalls 16 Products as Salmonella Probe Widens 2Health News:Kellogg Recalls 16 Products as Salmonella Probe Widens 3Health News:Kellogg Recalls 16 Products as Salmonella Probe Widens 4
Used to negotiate tortuous vessels....
BiodivYsio stent with biocompatible coating (phosphorylcholine)...
... The CYPHER Sirolimus-eluting Coronary Stent ... drug, called "sirolimus", a controlled-release ... delivery platform. Upon placement, sirolimus ... and impedes the process of ...
PT wires combine the enhanced durability of a linear elastic nitinol distal core and a highly resilient polymer tip. This provides excellent access in difficult cases involving severe tortuosity, tig...
Medicine Products: